James L Heppell - Net Worth and Insider Trading
James L Heppell Net Worth
The estimated net worth of James L Heppell is at least $11,420 dollars as of 2024-11-10. James L Heppell is the Director of Skye Bioscience Inc and owns about 2,000 shares of Skye Bioscience Inc (SKYE) stock worth over $11,420. Details can be seen in James L Heppell's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James L Heppell has not made any transactions after 2020-08-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James L Heppell
James L Heppell Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James L Heppell owns 3 companies in total, including Skye Bioscience Inc (SKYE) , Sophiris Bio Inc (SPHS) , and Inovio Pharmaceuticals Inc (INO) .
Click here to see the complete history of James L Heppell’s form 4 insider trades.
Insider Ownership Summary of James L Heppell
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| SKYE | Skye Bioscience Inc | 2020-08-07 | director |
| SPHS | Sophiris Bio Inc | 2019-06-27 | director |
| INO | Inovio Pharmaceuticals Inc | 2003-08-08 | director |
James L Heppell Latest Holdings Summary
James L Heppell currently owns a total of 1 stock. James L Heppell owns 2,000 shares of Skye Bioscience Inc (SKYE) as of August 7, 2020, with a value of $11,420.
Latest Holdings of James L Heppell
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SKYE | Skye Bioscience Inc | 2020-08-07 | 2,000 | 5.71 | 11,420 |
Holding Weightings of James L Heppell
James L Heppell Form 4 Trading Tracker
According to the SEC Form 4 filings, James L Heppell has made a total of 1 transactions in Skye Bioscience Inc (SKYE) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Skye Bioscience Inc is the acquisition of 2,000 shares on August 7, 2020, which cost James L Heppell around $25.0 Billion.
Insider Trading History of James L Heppell
- 1
James L Heppell Trading Performance
GuruFocus tracks the stock performance after each of James L Heppell's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by James L Heppell is -13.15%. GuruFocus also compares James L Heppell's trading performance to market benchmark return within the same time period. The performance of stocks bought by James L Heppell within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James L Heppell's insider trading performs compared to the benchmark.
Performance of James L Heppell
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.37 | | | | | |
| Relative Return to S&P 500(%) | -5.63 | | | | | |
James L Heppell Ownership Network
Ownership Network List of James L Heppell
Ownership Network Relation of James L Heppell
James L Heppell Owned Company Details
What does Skye Bioscience Inc do?
Who are the key executives at Skye Bioscience Inc?
James L Heppell is the director of Skye Bioscience Inc. Other key executives at Skye Bioscience Inc include 10 percent owner 5am Partners Vii, Llc , director & 10 percent owner Andrew J. Schwab , and 10 percent owner John D Diekman .
Skye Bioscience Inc (SKYE) Insider Trades Summary
Over the past 18 months, James L Heppell made no insider transaction in Skye Bioscience Inc (SKYE). Other recent insider transactions involving Skye Bioscience Inc (SKYE) include a net purchase of 5,389,737 shares made by 5am Partners Vii, Llc , a net purchase of 1,762,000 shares made by Punit Dhillon , and a net sale of 266,337 shares made by Andrew J. Schwab .
In summary, during the past 3 months, insiders sold 532,674 shares of Skye Bioscience Inc (SKYE) in total and bought 0 shares, with a net sale of 532,674 shares. During the past 18 months, 532,674 shares of Skye Bioscience Inc (SKYE) were sold and 5,663,122 shares were bought by its insiders, resulting in a net purchase of 5,130,448 shares.
Skye Bioscience Inc (SKYE)'s detailed insider trading history can be found in Insider Trading Tracker table.
Skye Bioscience Inc Insider Transactions
James L Heppell Mailing Address
Above is the net worth, insider trading, and ownership report for James L Heppell. Currently GuruFocus does not have mailing address information for James L Heppell.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
